Related Experiment Video
Updated: Jan 27, 2026
07:40
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
4.6K
Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by
Sofía Carbajosa1, María Florencia Pansa1, Natalia S Paviolo2
1Centro de Investigaciones en Bioquímica Clínica e Inmunología, CIBICI-CONICET, Departamento de Bioquímica Clínica, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba, Argentina.
Summary
BRCA1-deficient cancers exhibit an addiction to Polo-like kinase 1 (PLK1). Inhibiting PLK1 offers a targeted therapy strategy for these cancers, with potential for patient stratification in clinical trials.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- BRCA1 and BRCA2 deficiencies are key drivers in human cancers, necessitating targeted therapies.
- Identifying synthetic lethal (SL) interactions is crucial for developing novel cancer treatments.
Purpose of the Study:
- To discover novel synthetic lethal relationships with therapeutic potential in BRCA-deficient cancers.
- To investigate the therapeutic implications of targeting Polo-like kinase 1 (PLK1) in BRCA1-deficient cells.
Main Methods:
- Phenotypic screening technology to identify SL interactions in BRCA1- and BRCA2-deficient cells.
- Validation using chimeric spheroids, dual-tumor xenografts, and retrospective analysis of The Cancer Genome Atlas (TCGA) breast cancer data.
- Kinase inhibitor library screening and mechanistic studies on cell division and centrosomal duplication.
Main Results:
- PLK1 inhibition demonstrated significant SL induction in BRCA1-deficient cells, independent of PARP inhibitors.
- BRCA1 downregulation and PLK1 inhibition caused aberrant mitosis, affecting centrosomal duplication and cytokinesis, thereby reducing clonogenic potential.
- High PLK1 expression was observed in BRCA1-deficient tumors, confirmed across various cellular and animal models.
Conclusions:
- BRCA1-deficient cancer cells show a dependency on PLK1 expression.
- PLK1 inhibitors represent a promising therapeutic avenue for BRCA1-deficient cancers.
- Patient stratification based on PLK1 expression can enhance clinical trial efficacy.
Related Concept Videos
02:54Protein Kinases and Phosphatases
15.1K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.1K
02:54Protein Kinases and Phosphatases
4.5K
4.5K
02:57Targeted Cancer Therapies
8.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.9K
02:41Lethal Alleles
18.0K
Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
18.0K
00:46Feedback Inhibition
57.1K
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.1K
02:55Synthetic Biology
5.6K
Synthetic biology is an interdisciplinary science that involves using principles from disciplines such as engineering, molecular biology, cell biology, and systems biology. It involves remodeling existing organisms from nature or constructing completely new synthetic organisms for applications such as protein or enzyme production, bioremediation, value-added macromolecule production, and the addition of desirable traits to crops, to name a few.
Golden rice
Golden rice is a genetically modified...
Golden rice
Golden rice is a genetically modified...
5.6K